Eldelumab (anti-IP-10) induction therapy for ulcerative colitis: a randomised; placebo-controlled; phase 2b study

Sandborn, WJ; Colombel, JF; Ghosh, S; Sands, BE; Dryden, G; Hebuterne, X; Leong, RW; Bressler, B; Ullman, T; Lakatos, Péter László; Reinisch, W; Xu, LA; Luo, A
Journal article
JOURNAL OF CROHNS & COLITIS vol.:10, issue.:4, p.:418-428.
ISSN: 1873-9946 1876-4479
URI: http://repo.lib.semmelweis.hu//handle/123456789/7350
10.1093/ecco-jcc/jjv224
xmlui.dri2xhtml.METS-1.0.item-mtmtid: 2984607
WoS ID: 000374262300007
PubMed ID: 26721935
Date: 2016

Show full item record

Files in this item

Icon
Name: 2984607.pdf
Size: 961.4Kb
Format: PDF
This file is available only from Semmelweis network

View/Open
Icon
Name: Final_SUPPLEMENTA ...
Size: 130.3Kb
Format: PDF
View/Open

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account